HRTX analyst estimates
Heron Therapeutics (HRTX) analyst ratings, the average price target and its range, and every firm's latest call.
HRTX analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jun 9, 2025 | H.C. Wainwright | Heron Therapeutics initiated with a Buy at H.C. Wainwright | $6.00 |
| May 16, 2024 | Northland Securities | Northland Reiterates Outperform Rating on Heron Therapeutics (HRTX) | $9.00 |
| Mar 13, 2024 | Needham | Heron Therapeutics (HRTX) PT Raised to $5 at Needham to reflect strong sales trends | $5.00 |
- 2 firms rate HRTX: 0 buy, 2 hold, 0 sell.
- The average price target is $6.67 from None analysts, from $5.00 to $9.00.
Updated 2026-11-10 15:45 UTC